Intensity Therapeutics, Inc. (INTS) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts INTS Hot Sheet
Join SI Premium – FREE
Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q1 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Diginex reports 77% revenue rise but $31M net loss in FY2026
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
